Nuzenio

Obesity Drug Pipeline

Obesity Drug Pipeline news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 7 publisher sources 100/100 entity strength

Latest news

VKTX Stock Steady After-Hours On Positive Obesity Drug Pipeline Progress - stocktwits.comstocktwits.com · Sat, 08 Aug 2026 10:01:00 GMTThe divide between Eli Lilly and Novo Nordisk is widening after their latest earnings - CNBCCNBC · Thu, 06 Aug 2026 13:45:29 GMTNovo CEO looks to speed up R&D as share drop shows gap with Lilly - ReutersReuters · Wed, 05 Aug 2026 15:33:40 GMTAmgen drops ph. 1 obesity drug, upping pressure on MariTide - Fierce BiotechFierce Biotech · Tue, 04 Aug 2026 20:23:55 GMTAmgen Lifts Outlook on Strong Drug Sales, to End Early Development of Obesity Treatment - WSJWSJ · Tue, 04 Aug 2026 20:14:00 GMTPfizer axes ex-Metsera obesity asset and GIPR prospect in quarterly clearout - Fierce BiotechFierce Biotech · Tue, 04 Aug 2026 12:47:33 GMTSanofi drug pipeline worries, Dupixent dependence shake shares - ReutersReuters · Thu, 30 Jul 2026 07:00:00 GMTCelltrion to unveil obesity drug milestone before year-end - The Korea HeraldThe Korea Herald · Wed, 29 Jul 2026 05:43:31 GMT

Timeline

Sat, 08 Aug 2026 10:01:00 GMTVKTX Stock Steady After-Hours On Positive Obesity Drug Pipeline Progress - stocktwits.com
Thu, 06 Aug 2026 13:45:29 GMTThe divide between Eli Lilly and Novo Nordisk is widening after their latest earnings - CNBC
Wed, 05 Aug 2026 15:33:40 GMTNovo CEO looks to speed up R&D as share drop shows gap with Lilly - Reuters
Tue, 04 Aug 2026 20:23:55 GMTAmgen drops ph. 1 obesity drug, upping pressure on MariTide - Fierce Biotech
Tue, 04 Aug 2026 20:14:00 GMTAmgen Lifts Outlook on Strong Drug Sales, to End Early Development of Obesity Treatment - WSJ
Tue, 04 Aug 2026 12:47:33 GMTPfizer axes ex-Metsera obesity asset and GIPR prospect in quarterly clearout - Fierce Biotech

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Obesity Drug Pipeline.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.